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Background: The microvascular benefits of intensive blood glucose control are well established but the question of whether this benefit extends 
to the macrovascular beds especially in terms of cardiovascular outcomes remains unanswered. We undertook a systematic review to address this 
question.
Methods: We reviewed comparative studies of intensive vs. conventional control of blood glucose in patients with type II diabetes using meta 
analytical methods.  The primary endpoints were all cause mortality and cardiac mortality. The secondary endpoints were stroke, PVD and MACE 
(defined as the composite of all cause mortality, nonfatal MI, stroke and PVD). Heterogeneity was assessed by Q statistic and sensitivity analysis was 
performed.
Results: Eight studies comprising 33,353 patients were included in the analysis. The mean length of follow-up was 6 years. The mean HbA1c level 
was lower in the intensive-control group (7.2% vs. 8.2%) and was associated with a decrease in cardiac mortality (OR 0.85; 95% CI: 0.76 to 0.96; 
Fig1) but not all cause mortality (OR 0.92; 95% CI: 0.79 to 1.07). While MACE (OR 0.85; 95% CI, 0.74 to 0.97) was also significantly decreased in 
the intensive treatment arm, stroke (OR 0.90; 95% CI: 0.79 to 1.04) and PVD (OR 0.93; 95% CI: 0.82 to 1.05) were similar with both strategies. 
There was no change in the results on sensitivity analyses.
Conclusion: Intensive blood-glucose control leads to a significant decrease in cardiac death and MACE in patients with type II diabetes.
